Temsirolimus for advanced renal cell carcinoma
Figlin, R.A.
Clinical Advances in Hematology and Oncology H&o 5(11): 893
2007
ISSN/ISBN: 1543-0790 PMID: 18185488 Document Number: 606150
Document emailed within 1 workday
Related Documents
Gerullis, H.; Ecke, T.H.; Eimer, C.; Heuck, C.J.; Otto, T. 2010: MTOR-inhibition in metastatic renal cell carcinoma. Focus on temsirolimus: a review Minerva Urologica e Nefrologica 62(4): 411-423Aulitzky, W.E.; Kaufmann, M. 2004: Immunotherapy for advanced renal cell carcinoma Der Urologe. Ausg. a 43(1): 85-92; Quiz 93
Matsuyama, H.; Yamamoto, N.; Sakatoku, J.; Hara, Y.; Sacho, T.; Yasui, H.; Ichikawa, T.; Koshido, Y.; Hayasida, S.; Nagata, K. 1988: Clinical study of UFT in far-advanced renal cell carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 527-530
Fujita, T.; Fukushima, M. 1992: Interferon therapy for advanced renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 38(11): 1293-1298
Tang, B.; Chi, Z.; Sheng, X.; Cui, C.; Si, L.; Kong, Y.; Li, S.; Mao, L.; Lian, B.; Wang, X.; Yan, X.; Guo, J. 2015: Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma Zhonghua Yi Xue Za Zhi 95(30): 2459-2461
Evans, W.K.; Shepherd, F.A.; Blackstein, M.E.; Osoba, D.; Taylor, D. 1985: Phase Ii evaluation of bisantrene in patients with advanced renal cell carcinoma Cancer Treatment Reports 69(6): 727-728
Elson, P.J.; Earhart, R.H.; Kvols, L.K.; Spiegel, R.; Keller, A.M.; Kies, M.S.; Davis, T.E.; Stevens, C.; Gumas, L.; Trump, D.L. 1987: Phase Ii studies of PCNU and bisantrene in advanced renal cell carcinoma Cancer Treatment Reports 71(3): 331-332
Panetta, A.; Martoni, A.; Guaraldi, M.; Tamberi, S.; Casadio, M.; Lelli, G.; Pannuti, F. 1994: Combined chemo-immuno-hormonotherapy of advanced renal cell carcinoma Journal of ChemoTherapy 6(5): 349-353
Omachi, T.; Sakamoto, W.; Kishimoto, T.; Kawano, M.; Oyama, A.; Kamizuru, M.; Maekawa, M.; Hagihara, S.; Nakamura, K. 1992: A case of renal cyst associated with renal cell carcinoma--characteristics of intracystic fluid associated with renal cell carcinoma from Japanese reports Hinyokika Kiyo. Acta Urologica Japonica 38(3): 323-326
Wada, T.; Nishiyama, K.; Maeda, M.; Hara, S.; Tanaka, N.; Yasutomi, M.; Kurita, T. 1995: Combined chemoendocrine treatment with tegafur and tamoxifen for advanced renal cell carcinoma Anticancer Research 15(4): 1581-1584
Huang, T.; Song, X-shuang.; Zhang, Z-wei. 2013: Efficacies of sorafenib plus interferon in advanced renal cell carcinoma: a report of 57 cases Zhonghua Yi Xue Za Zhi 93(24): 1903-1905
Voravud, N.; Sriuranpong, V.; Lertsaguansinchai, P. 2000: Recombinant interferon-alpha 2b and megestrol acetate in patients with advanced renal cell carcinoma Journal of the Medical Association of Thailand 83(2): 123-128
Kurth, K.H.; Marquet, R.; Zwartendijk, J.; Warnaar, S.O. 1987: Autologous anticancer antigen preparation for specific immunotherapy in advanced renal cell carcinoma European Urology 13(1-2): 103-109
Hamada, I.; Kato, M.; Okada, K. 2002: Multi-cytokine therapy for advanced renal cell carcinoma: determination of the minimal effective dose Anticancer Research 22(4): 2429-2436
Imada, K.; Eto, M. 2019: Ⅱ. how Has the Treatment Outcomes for Advanced Renal Cell Carcinoma Improved in the 10 Years after Approval of Targeted Therapy ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(1): 40-44
Schulman, P.; Davis, R.B.; Rafla, S.; Green, M.; Henderson, E. 1984: Phase Ii trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study Cancer Treatment Reports 68(10): 1305-1306
Buter, J.; Sleijfer, D.T.; van der Graaf, W.T.; de Vries, E.G.; Willemse, P.H.; Mulder, N.H. 1993: A progress report on the outpatient treatment of patients with advanced renal cell carcinoma using subcutaneous recombinant interleukin-2 Seminars in Oncology 20(6 Suppl. 9): 16-21
Nishio, Y.; Nishimura, K.; Hida, S.; Okada, Y.; Takeuchi, H.; Miyakawa, M.; Okada, K.; Yoshida, O. 1987: Results of radical nephrectomy for renal cell carcinoma. Report 1. Analysis according to the TNM staging system of the general rule for clinical and pathological studies on renal cell carcinoma Hinyokika Kiyo. Acta Urologica Japonica 33(3): 337-343
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Trump, D.L.; Elson, P.J.; Borden, E.C.; Harris, J.E.; Tuttle, R.L.; Whisnant, J.K.; Oken, M.M.; Carignan, J.R.; Ruckdeschel, J.C.; Davis, T.E. 1987: High-dose lymphoblastoid interferon in advanced renal cell carcinoma: an Eastern Cooperative Oncology Group Study Cancer Treatment Reports 71(2): 165-169